U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2018
436
Name Type Language
TILDRAKIZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
TILDRAKIZUMAB, LICENSE HOLDER UNSPECIFIED
Preferred Name English
TILDRAKIZUMAB [JAN]
Common Name English
MK-3222
Code English
Tildrakizumab [WHO-DD]
Common Name English
tildrakizumab [INN]
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL23A (INTERLEUKIN 23 ALPHA SUBUNIT (P19), IL-23A)), HUMANIZED MONOCLONAL ANTIBODY
Common Name English
TILDRAKIZUMAB [MI]
Common Name English
SCH-900222
Code English
TILDRAKIZUMAB [USAN]
Common Name English
Classification Tree Code System Code
NDF-RT N0000192799
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
WHO-ATC L04AC17
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
Code System Code Type Description
ChEMBL
CHEMBL2108681
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
PRIMARY
USAN
ZZ-43
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
PRIMARY
LACTMED
Tildrakizumab
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
PRIMARY
CAS
1326244-10-3
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
PRIMARY
DRUG CENTRAL
5281
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
PRIMARY
MERCK INDEX
m12075
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
PRIMARY
DRUG BANK
DB14004
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
PRIMARY
EVMPD
SUB130334
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
PRIMARY
DAILYMED
DEW6X41BEK
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
PRIMARY
NCI_THESAURUS
C152627
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
PRIMARY
FDA UNII
DEW6X41BEK
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
PRIMARY
RXCUI
2053436
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
PRIMARY
WIKIPEDIA
Tildrakizumab
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
PRIMARY
RXCUI
2053449
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
ALTERNATIVE
SMS_ID
100000156428
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
PRIMARY
INN
9672
Created by admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
PRIMARY
ACTIVE MOIETY
TILDRAKIZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966